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ABSTRACT
Cornea is a clear outermost layer of the eye which enables transmission of light onto the retina.
The transparent corneal epithelium is regenerated by limbal stem cells (LSCs), whose loss/dys-
function results in LSCs deficiency (LSCD). Ex vivo expansion of autologous LSCs obtained from
patient’s healthy eye followed by transplantation onto the LSCs damaged/deficient eye, has pro-
vided a successful treatment for unilateral LSCD. However, this is not applicable to patient with
total bilateral LSCD, where LSCs are lost/damaged from both eyes. We investigated the potential
of human induced pluripotent stem cell (hiPSC) to differentiate into corneal epithelial-like cells
as a source of autologous stem cell treatment for patients with total bilateral LSCD. Our study
showed that combined addition of bone morphogenetic protein 4 (BMP4), all trans-retinoic acid
and epidermal growth factor for the first 9 days of differentiation followed by cell-replating on
collagen-IV-coated surfaces with a corneal-specific-epithelial cell media for an additional 11
days, resulted in step wise differentiation of human embryonic stem cells (hESC) to corneal epi-
thelial progenitors and mature corneal epithelial-like cells. We observed differences in the abil-
ity of hiPSC lines to undergo differentiation to corneal epithelial-like cells which were
dependent on the level of endogenous BMP signaling and could be restored via the activation
of this signaling pathway by a specific transforming growth factor b inhibitor (SB431542).
Together our data reveal a differential ability of hiPSC lines to generate corneal epithelial cells
which is underlined by the activity of endogenous BMP signaling pathway. STEM CELLS 2017;
00:000–000
SIGNIFICANCE STATEMENT
Directing differentiation of human induced pluripotent stem cells (hiPSC) to corneal epithelial
progenitors could provide an autologous source for cell replacement therapy in patients with
bilateral limbal stem cell deficiency, avoiding dependency on post-transplant immunosuppres-
sant or donated cornea. This work describes a simple and efficient two-step method with the
supplementation of growth factors and small molecules that results in differentiation of plurip-
otent stem cells to corneal epithelial cells in 20 days. There were cell line differences in capac-
ity to differentiate to corneal epithelial progenitors which were underlined by the endogenous
BMP signaling activity and could be restored using SB431542.
INTRODUCTION
Cornea is the transparent region at the front
of the eye which enables transmission of light
to the retina. It comprises the corneal epithe-
lium, stroma, and endothelium. The corneal
epithelium is continuously regenerated by lim-
bal stem cells (LSCs) [1, 2], which migrate
from peripheral to central region of the cornea
and ascend from basal to superficial layer to
differentiate and form a new stratified layer of
non-keratinized squamous epithelium [3]. The
corneal epithelium develops from surface ecto-
derm [4], while the stroma and endothelium
developed from the mesenchymal tissue and
neural crest cells [5].
LSCs deficiency (LSCD) is a disease caused
by the loss or dysfunction of LSCs, leading to
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loss of corneal epithelial integrity and function, often resulting
in persistent pain and severe visual impairment [6]. Work done
by our group and others have shown that the transplantation of
ex vivo expanded autologous LSCs is able to reconstruct the cor-
neal surface and to restore vision in patients with unilateral
total LSCD [7–9]. However, this treatment is not applicable to a
significant number of patients with total bilateral LSCD where
patient’s both eyes are devoid of LSCs which are needed for the
ex vivo expansion and subsequently used for transplantation.
Hence, alternative sources of cells that could be used to replace
the missing LSCs in total bilateral LSCD are being sought after
by many researchers. Of those, transplantation of ex vivo
expanded autologous oral mucosa epithelial (OME) cells has
been the most used cell source in clinical studies of bilateral
LSCD treatment with a reported “success” rate of 48%–75%
within follow-up times up to 34 months [10–17]. Our group pro-
vided proof of concept by transplanting autologous ex vivo
expanded OME in two patients with histologically confirmed
total bilateral LSCD which resulted in successful reversal of
LSCD in the treated eye up to 24 months [18]. Notwithstanding,
we also showed that cultured oral epithelial cells retained a
gene expression profile that was attributed to epithelial stem
cells in general, but they did not acquire a typical limbal expres-
sion pattern after 10–14 days in culture [18], thus indicating
that the transplanted cells did not fully transdifferentiate into
corneal epithelium.
Recent advances in somatic cell induced reprogramming
have shown that it is possible to reprogram somatic cells
back to an “embryonic-like cells” through overexpression of
four key pluripotency factors. These are named induced plu-
ripotent stem cells and like human embryonic stem cells
(hESC), they are characterized by unlimited self-renewal and
potential to differentiate into any cell type of the adult organ-
ism [19, 20]. The most important advantage of human
induced pluripotent stem cells (hiPSC) is the ability to avoid
post-transplantation rejection by patient’s own immune sys-
tem [21]. Traditionally, differentiation of hESC and hiPSC to
corneal epithelial cells has relied on usage of feeder cells,
undefined conditioned media, or amniotic membrane [22–26].
More recently, small molecule driven protocols have become
available resulting in generation of corneal epithelial-like cells
within 6 weeks [27]. Bioengineered medical grade collagen
matrices have also been shown to provide an excellent carrier
for pluripotent stem cell derived limbal epithelial cells, which
retained their ability to proliferate when in contact with
matrix as well as the ability to differentiate into epithelial
cells [28]. In this article, we describe the development of a
defined feeder-free monolayer differentiation method which
results in differentiation of hESC and hiPSC to corneal epithe-
lial progenitors and mature corneal epithelial cells within 20
days. Furthermore, we show differences in the ability of hiPSC
lines to generate corneal epithelial-like cells which are dic-
tated by the activity of endogenous bone morphogenetic pro-
tein (BMP) signaling pathway.
MATERIALS AND METHODS
Cell Culture
Undifferentiated hESC (H9) and hiPSC that were generated
and fully characterized in our group (SB-Ad2 and SB-Ad3 [29])
were maintained in BD Matrigel (growth factor reduced) (BD
Biosciences, Belgium) with mTeSR1 (STEMCELL Technologies,
Cambridge, MA) at 378C and 5% CO2. hESC and hiPSC were
passaged every 3–4 days by using 0.02% EDTA (Versene, Bel-
gium) at 1:3–1:6 ratio. 3T3 fibroblasts for feeder plate prepa-
ration were maintained in cell culture flasks in fibroblast
medium at 378C and 5% CO2. 3T3 fibroblast medium was pre-
pared by mixing 89% high glucose Dulbecco’s modified Eagle
medium1GlutaMAX; 10% fetal bovine serum (FBS); 1% Pen/
Strep (Gibco, UK). 3T3 fibroblasts were passaged every 3 to 4
days using 0.05% Trypsin-EDTA (Gibco, UK). All cells used in
this study were between passages 15 and 50 and assessed to
be karyotypically normal through CytoSNP analysis.
Differentiation of hESC and hiPSC to Corneal Epithelial
Cells
A schematic representation of differentiation protocol is pre-
sented in Figure 1A. In brief, hESC and hiPSC were seeded at
1.7 3 104 cells per square centimeter [30] on BD Matrigel-
coated plates and kept in mTeSR1 medium for two days. Rho
kinase inhibitor, Y27632 (Chemdea, NJ, USA) [10 mM) was
added to the mTeSR1 medium for the first 24 hours. Eight dif-
ferentiation induction media listed in Figure 1B were intro-
duced to the cells according to the respective groups on day
3 and maintained until day 9. The cells were then replated at
1.7 3 104 cells per square centimeter onto 0.05 mg/ml
collagen-IV–coated plates [22] on day 9 and supplemented
with CnT-Prime medium (CELLnTEC, Switzerland) and 10%
serum for the next 11 days. Three technical and three biologi-
cal repeats were set up for each differentiation group.
Optimization of hiPSC Differentiation Using SB431542
hiPSC were seeded at 1.7 3 104 cells per square centimeter
on BD Matrigel coated plates and kept in mTeSR1 medium for
2 days, with 10 mM Rho kinase inhibitor, Y27632 (Chemdea,
NJ, USA) added for the first 24 hours. The SB431542 (10 mM)
(Tocris, UK) was added to the differentiation media from day
3 for 1, 2, or 3 days. The cell were replated at 1.7 3 104 cells
per square centimeter onto collagen-IV-coated plates at day 9
and supplemented with CnT-Prime medium (CELLnTEC, Swit-
zerland) and 10% serum for the next 11 days. Three technical
and three biological repeats were set up for each differentia-
tion group.
RNA Extraction, Reverse Transcription, and
Quantitative Real-Time Polymerase Chain Reaction
RNA was extracted from the cells collected from differentiat-
ing hESC and hiPSC at days 0, 9, and 20 using the ReliaPrep
RNA Cell Miniprep System (Promega, WI). The RNA quality
was evaluated using the Nanodrop 2000 spectrophotometer
(Thermo Fisher Scientific, MA). One microgram of extracted
RNA was converted into cDNA using reverse transcription
(GoScript Transcription System; Promega, WI) following the
manufacturer’s instructions. Quantitative real-time polymerase
chain reaction (qRT-PCR) was carried out using the QuantStu-
dio 7 Flex Real-Time PCR System (Thermo Fisher Scientific,
MA) and GoTaq qPCR Master Mix (Promega, WI) according to
manufacturer’s instructions. The primer sequences used are
listed in Supporting Information Table S1. The data were ana-
lyzed using the DDCt calculation method.
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Figure 1. Schematic outline of the differentiation process. The differentiation process is divided into two stages, early (days 0–9) and
advanced (days 10–20) (A). Endpoint analyses included quantitative real-time polymerase chain reaction (qRT-PCR), immunocytochemis-
try, and colony forming efficiency. List of differentiation induction media components for each of the eight groups (B). Downregulation
of OCT4 from days 0 to 9 for all the groups in the three cell lines used (H9, SB-Ad2, and SB-Ad3) assessed by qRT-PCR (C). Data are pre-
sented as mean6 SEM, n5 3. *, statistically different compared with day 0. ****, p< .0001. Abbreviations: BMP4, bone morphogenetic
protein 4; CFE, colony forming efficiency; EGF, epidermal growth factor; ICC, immunocytochemistry; IWP-2, Wnt antagonist II; qPCR,
quantitative polymerase chain reaction.
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Colony Forming Efficiency Assay
3T3 cells were mitotically inactivated with mitomycin C (10 mg/
ml) (Sigma-Aldrich, Germany) for 2 hours as described by
Ahmad et al. [22]. Then 2.4 3 104 per square centimeter of
the cells were added into each well of the six-well gelatin-
coated plates containing fibroblast medium. The plated cells
were incubated at 378C in 5% CO2. The feeder plates were
used on the following day. On day 9 or day 20, 1,000 cells
from each experimental group were added to each feeder well
containing limbal epithelial medium [7]. The limbal epithelial
medium was replaced after 3 days and every other day there-
after. The colony forming efficiency (CFE) plates were kept for
14 days. The CFE plates were fixed in 3.7% formaldehyde for
10 minutes at room temperature. The wells were washed with
phosphate-buffered saline (PBS) once before enough volume of
1% Rhodamine B (Sigma-Aldrich, Germany) in methanol was
added to each well and incubated for 10 minutes. Cell colonies
were washed three times with PBS before being observed and
counted with the aid of a dissection microscope.
Immunofluorescence Staining
Cells on day 9 or day 20 of differentiation were dissociated
using Tryple express (Gibco, UK) and kept in PBS supple-
mented with 2% FBS on ice. Cells were cytospun into poly-L-
lysine-coated slides, fixed with 4% paraformaldehyde (Sigma-
Aldrich, Germany) for 15 minutes. Nonspecific staining was
inhibited by blocking in 5% normal goat serum for 1 hour at
room temperature. Primary antibody was added overnight at
48C followed by washes and incubation with a secondary anti-
body at room temperature in a dark humidified chamber for
1 hour. Slides were protected from light as much as possible
after the addition of secondary antibody to avoid bleaching of
the fluorescence signal. Following staining, cells were washed
three times with PBS, with each wash lasting for 3 minutes.
Vectashield mounting medium (Vector Laboratories, Burlin-
game, CA) with Hoechst (Thermo Fisher Scientific, UK)
(1:2,000) was added carefully before mounting the coverslips.
A list of antibodies used and all dilutions are presented in
Supporting Information Table S2.
Microscopy
Cell morphology was observed and digital images were taken
using a microscope (Zeiss AxioVert 1, Germany). ImageJ soft-
ware was then used to count the stained and unstained cells
from the pictures. Five fields, each containing more than 100
cells, were counted for each group.
Transfection of BMP Reporter Plasmid
Lipofectamine 3000 reagent (Thermo Fisher, Waltham, MA)
was used for BMP reporter plasmid (Addgene, MA) transfec-
tion. Cells were disassociated by incubating with EDTA (0.02%)
for 5 minutes. The disassociated cells were collected and cen-
trifuged at 500g for 5 minutes. The cell pellet was resus-
pended into 2 ml of media and cell count was performed
before replating cells at the density of 1.3 3 105 cells into
one well of a BD Matrigel coated 24 well plate one day
before lipofection. For plasmid lipofection, 500 ng of pGL3-
Basic or pGL3 BRE Luciferase (Promega, Madison, WI) were
used to transfect the cells in each well of 24-well plate fol-
lowing manufacturer’s recommendations. Cells that were
transfected with empty vector (pGL3-Basic) or BMP reporter
(pGL3 BRE Luciferase) were cotransfected with empty Renilla
vector (pRL-Null) (Promega, Madison, WI).
Luciferase Assays
Transfected cells were cultured in mTeSR1 alone or mTeSR1
supplemented with BMP4 or BMP4 and SB431542. Cell extracts
were prepared 48 hours after transfection using a passive lysis
buffer. Luciferase activities were evaluated with a Dual-
Luciferase Assay System (Promega, Madison, WI) according to
the manufacturer’s recommendations using Varioskan LUX plate
reader (Thermo Fisher Scientific, Waltham, MA). Background
luminescence was determined using untransfected cells and
the background readings were then subtracted from the result-
ing luminescence readings before being normalized to Renilla
luminescence and presented as relative luminescence unit.
Statistical Analysis
Statistical analysis was performed with one-way analysis of
variance analysis with GraphPad Prism 7 software. Unless oth-
erwise stated in all figures data are shown as mean6 SEM
(n5 3). *, p< .05; **, p< .01; ***, p< .001; ****, p< .0001.
RESULTS
Differentiation of hESC and hiPSC to Corneal Epithelial
Progenitors
One hESC (H9) and two hiPSC (SB-Ad2 and SB-Ad3) lines were
directed to differentiate to corneal epithelial-like cells using a
two stage differentiation protocol which aimed at generating
corneal epithelial progenitors (days 0–9) and their further dif-
ferentiation to mature corneal epithelial cells (days 10–20). In
the first 9 days, the serum-free medium was supplemented
with a range of growth factors and signaling molecules which
included BMP4 and all-trans retinoic acid (RA) known to pro-
mote non-neural ectodermal differentiation [31, 32], and epi-
dermal growth factor (EGF) which stimulates the proliferation
of corneal epithelial progenitors [33]. Inhibition of Wnt and
transforming growth factor (TGF) b pathway have been
reported to be necessary for guiding differentiation of hESC
and hiPSC to a ventral neural fate and eye field determina-
tion; hence, we included IWP-2, a Wnt/b-catenin pathway
inhibitor, and SB505124, a selective TGFb type 1 receptor
inhibitor, either on their own or in combination with BMP4 in
groups 6 and 7, respectively [27]. We also included one addi-
tional group with a BMP pathway inhibitor (LDN 193189) to
control for the impacts of BMP4, which we used to induce
commitment to non-neural ectoderm. A total of seven combi-
nations of growth factors and signaling molecules were
tested, along with the basal medium alone in three indepen-
dent differentiation experiments for each cell line. The differ-
entiation induction media and the plate coating were
changed on day 9 to CnT-Prime with 10% fetal bovine serum
and collagen-IV coating, respectively, to promote the differen-
tiation of corneal epithelial progenitors into mature corneal
epithelial-like cells. A Schematic outline of the differentiation
protocol is detailed in Figure 1A and 1B.
We noticed similar morphological changes observed for
both hESCs and hiPSC (Supporting Information Fig. S1A–S1C).
The experimental groups 2, 3, and 5 showed the most
4 hESC and hiPSC differentiation to Corneal Cells
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differentiated morphology typical of epithelial cells on day 9
for both hESC and hiPSC (Supporting Information Fig. S1A–
S1C, black arrows). The differentiated cells grew into pockets
of flatter and larger cells with higher cytoplasm to nucleus
ratio in between the smaller undifferentiated stem cells, cor-
roborating similar observations published by Xu et al. [34]. In
contrast, most cells in the experimental groups 1, 4, 6, and
8 proliferated robustly and retained the small and compact
cell appearance. qRT-PCR analysis indicated that on day 9, all
experimental groups across hESC and hiPSC differentiations
were associated with loss of the pluripotent phenotype as
shown by a significant decrease in the expression of OCT4
(Fig. 1C).
To assess the differentiation efficiency and compare the
effects of media supplementation across the eight groups,
qRT-PCR analysis was carried out at day 9 of differentiation.
The results for each group were compared with the control
group (G1) which contained no growth factors or small
molecules supplementation and presented as z scores. Addi-
tion of BMP4 has been associated with differentiation of hESC
and hiPSC to mesodermal lineages [35]; however, a significant
increase in the expression of mesodermal marker, BRACHYURY
was only observed in the hESC (H9) and one hiPSC line (SB-
Ad2; Fig. 2A) upon BMP4 treatment (Group 2). The expression
of RAX, a gene expressed in the eye primordia and required
for retinal cell fate determination [36], was significantly down-
regulated in groups 2–7 for both hESC and hiPSC, thus indicat-
ing that in all these groups, the differentiation to
neuroectodermal lineages was avoided (Fig. 2B). BMP4 is
expressed in early ectodermal tissue [32, 37] and is often
used as marker of non-neural ectoderm, developing cornea
and lens. Our qRT-PCR analysis indicated a significant upregu-
lation of BMP4 in experimental groups 2, 3, and 5 of hESC
and two hiPSC (Fig. 2C), suggesting that the differentiation
factors added to these three groups encouraged differentia-
tion to non-neural ectoderm [30]. The expression of
Figure 2. Bone morphogenetic protein 4 (BMP4), retinoic acid, and epidermal growth factor improve early corneal/limbal differentia-
tion process. Quantitative real-time polymerase chain reaction analysis of BRACHYURY, RAX, BMP4, CK8, ECADHERIN, and DNp63 genes
for groups G2–G8 compared with control group (G1) presented as z scores (A–F). z score was calculated using the following formula: z
score5D/SEM where D is the difference between the two means and SEM is the standard error of mean (computed from the data).
Dotted lines represent 90% confidence level. Abbreviation: BMP4, bone morphogenetic protein 4.
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ectodermal cytokeratin 8 (CK8), basal, and suprabasal corneal
epithelium (E-CADHERIN) and putative LSCs (DNp63) markers
were all significantly increased in experimental groups 3 and
5 of both hESCs and hiPSC (Fig. 2D–2F), indicating a likely
commitment of these groups to corneal epithelial progenitors.
The z scores from the qRT-PCR analysis consistently indi-
cated that the experimental groups that were supplemented
with BMP4, RA, and a combination of BMP4, RA, and EGF
showed a significant upregulation of non-neural ectoderm, epi-
thelial, cell junction, and putative LSC markers. Therefore, we
went on to analyze these groups by immunostaining for the
expression of putative LSCs protein, DNp63. No significant dif-
ferences between the control nonsupplemented groups and the
ones that received BMP4, RA, and a combination of BMP4, RA,
and EGF were found (Fig. 3A, 3B). These immunostaining results
do not corroborate the qRT-PCR analysis and a possible reason
for this may be the post-translational modifications already
reported for the p63 protein [38]. Expression of PAX6, a marker
of neuroectodermal [39], anterior placodal ectoderm, and
developing eye and lens, was significantly highest in groups
treated with RA and a combination of BMP4, RA, and EGF for
the differentiating hESC and one of the hiPSC (Fig. 3B).
CFE was highest in experimental groups 2 and 5 of hESC
and one of the hiPSC lines (SB-Ad2, Fig. 3C), suggesting that
supplementation of basic media with BMP4 or a combination
of BMP4, RA, and EGF provides an optimal combination for
directing differentiation of hESC and hiPSC to corneal epithe-
lial progenitor cells. Notwithstanding, no significant difference
in CFE ability was observed between the four experimental
groups tested in the second hiPSC line (SB-Ad3), indicating
significant differences between the hiPSC lines in their
response to our differentiation protocols and the need for fur-
ther culture modifications for nonresponsive hiPSC lines.
Differentiation of hESC and hiPSC to Corneal
Epithelial-Like Cells
During the second differentiation window (days 10–20), we
aimed at promoting the maturation of corneal epithelial pro-
genitors to epithelial cells by replating on collagen-IV coated
plates and feeding the cells with a specific corneal differentia-
tion medium (CnT-Prime) supplemented with 10% serum (Fig.
1A). Similar morphological changes were observed in both
hESC and hiPSC during this time window (Fig. 4A; Supporting
Information Figs. 2A, 3A). Cells appeared larger and flatter
and characterized by an epithelial-like morphology by the end
of the experiment on day 20. qRT-PCR analysis showed that
the combination of RA, BMP4, and EGF (group 5) was associ-
ated with the greatest upregulation of putative LSC marker
(DNp63) across the cell lines (Fig. 4B; Supporting Information
Figs. 2B, 3B). Expression of ABCG2, which was reported as
another putative LSCs marker [40], was also consistently high-
est in groups supplemented with RA across the cells lines. Dif-
ferentiated corneal epithelial cytokeratin, CK3 expression was
more variable across the cell lines, with the highest expres-
sion observed in BMP4 supplemented group for hESC, RA sup-
plemented group for hiPSC-SB-Ad3 and RA and RA, BMP4,
and EGF supplemented group for hiPSC-SB-Ad2. CK12 expres-
sion was consistently highest in the groups supplemented
with RA, BMP4, and EGF. Together, these data suggest some
intra-line differences in the capacity to mature toward corneal
epithelial-like cells.
Immunostaining analysis at day 20 revealed a significant
upregulation of DNp63 expression in groups supplemented
with BMP4, RA, and EGF across the hESC and hiPSC lines (Fig.
5A). It needs to be noted though that the expression of this
marker decreased from day 9 of differentiation, indicating fur-
ther differentiation of these cells to CK3 and CK12 expressing
corneal epithelial cells as shown in Supporting Information
Figure 4A and 4B. CFE assays also showed that the BMP4, RA,
and EGF supplemented group in hESC resulted in the highest
colony forming ability which was similar to human limbal epi-
thelial progenitor cells (Fig. 5B). All the selected groups of
one of the hiPSC lines (SB-Ad2) showed an increased CFE abil-
ity compared with control group; however, this was consider-
ably lower than human limbal epithelial progenitor cells (Fig.
5B). In contrast, all the treated groups from the second hiPSC
line (SB-Ad3) showed a very low CFE ability and no difference
to the untreated control group, indicating a lack of response
from this cell line to differentiation factors added during the
20 day time window.
Differences in the Activity of Endogenous BMP
Signaling Pathway Between Responsive and
Nonresponsive hiPSC Lines
This study data and others indicate that BMP4 is a key driver of
pluripotent stem cell differentiation toward non-neural ecto-
derm [41, 42]. Since one of the hiPSC lines was not responsive
to the differentiation method, we investigated whether differ-
ences in the endogenous activity of BMP pathway between
hiPSC lines could be the underlying mechanism. We first carried
out qRT-PCR analysis which indicated that although the non-
responsive hiPSC line (SB-Ad3) expressed higher levels of
endogenous BMP4 when compared with the responsive hiPSC
line, SB-Ad2 (Supporting Information Fig. S5), the expression of
key receptors (BMPR1A and BMPR1B) and receptor activated
SMAD1 and SMAD5 genes that mediate BMP signaling were sig-
nificantly lower, suggesting that this hiPSC line may be charac-
terized by a much lower level of endogenous BMP activity. This
is further corroborated by low expression of two BMP target
genes, ID1 and JUNB, which were expressed at a lower level in
the nonresponsive hiPSC line when compared with the respon-
sive line. Since both the receptor and effector genes expressions
are lower, addition of exogenous BMP4 alone (as in our differ-
entiation methods), is unlikely to activate the pathway in the
nonresponsive hiPSC line.
To confirm this further, a BMP reporter plasmid was trans-
fected in both hiPSC lines causing a transient overexpression of
BMP specific gene, ID1 [43]. The reporter analyses showed that
the SB-Ad3 iPSC line has a significantly lower endogenous BMP
activity compared with SB-Ad2 iPSC (Supporting Information
Fig. S6A). Addition of BMP4 increased the BMP activity of both
hiPSCs; however, SB-Ad3 iPSC still lagged behind SB-Ad2 (Sup-
porting Information Fig. S6B). Combined addition of BMP4 and
SB435142 did not have a significant impact on SB-Ad2; however,
it increased the endogenous BMP activity of Sb-Ad3 hiPSC to
the same levels as SB-Ad3 (Supporting Information Fig. S6B).
Specific TGFb Inhibitor, SB431542, Induces the
Differentiation of Nonresponsive hiPSC Lines to
Corneal Epithelial Cells
Given the low level of BMP receptor and effector expression
in the nonresponsive hiPSC line, we aimed to improve the
6 hESC and hiPSC differentiation to Corneal Cells
VC 2017 The Authors STEM CELLS published by Wiley Periodicals, Inc. on behalf of AlphaMed Press STEM CELLS
differentiation method by altering the co-SMAD/r-SMAD inter-
action in the cytoplasm. Since co-SMAD (SMAD4) is shared
between TGFb and BMP pathways [44, 45], we focused on
the inhibition of the TGFb pathway which should lead to an
increase in the availability of SMAD4 for the BMP pathway. To
achieve this, a selective TGFb inhibitor, SB431542, which has
been reported to drive differentiation away from neuro-
ectoderm [35] and to activate the BMP pathway [46], was
Figure 3. DNp63 protein expression and colony forming efficiency. Immunocytochemistry analyses for differentiated cells on day 9 for
G1, G2, G3, and G5. Representative immunofluorescence images showing positive DNp63 and PAX6 nuclear staining in G3 of H9 cells
(A) and percentage of DNp63 and PAX6 positive cells for H9, SB-Ad2, and SB-Ad3 (B). Colony forming efficiency assays for the three cell
lines on day 9 for G1, G2, G3 G5, and human limbal epithelium (C). Scale bar5 50 mm. Data are presented as mean6 SEM, n5 3. *,
statistically different compared with G1. *, p< .05; **, p< .01; ***, p< .001; ****, p< .0001. Abbreviations: CFE, colony forming effi-
ciency; DAPI, 40,6-diamidino-2-phenylindole.
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used. SB431542 (10 mM) was added for 1, 2, and 3 days to
the differentiation media in combination with BMP4, RA, and
EGF as detailed in Figure 6A. qRT-PCR analysis at day 20 indi-
cated the highest expression of DNp63 in groups treated for 2
and 3 days with SB431542 (Fig. 6B). Interestingly, only the
group treated for 3 days with SB431542 showed enhanced
CFE ability to similar levels observed with human limbal epi-
thelial progenitor cells (Fig. 6C), suggesting that continuous
inhibition of TGFb pathway for 3 days with this specific TGFb
inhibitor, can result in differentiation of nonresponsive hiPSC
lines to corneal epithelial progenitor cells (please refer to
graphical abstract). It is of interest to note that SB431542 on its
own was not able to achieve the upregulation of DNp63 observed
after combined addition of BMP4 and SB431542 (Fig. 6B).
DISCUSSION
Efficient differentiation of a large numbers of hESC and hiPSC
for autologous cell replacement therapies using robust and
fast protocols has become an important aim for most
researchers in the field. In this paper, we report a feeder-free,
two-step method that results in differentiation of hESC to cor-
neal epithelial progenitors and mature corneal epithelial-like
cells within 20 days. Previous studies in the field have
Figure 4. Cell morphology at advanced stage of differentiation and molecular characterization. Differentiated G1, G2, G3, and G5 of H9
cells morphological appearance on day 20 (A), and quantitative real-time polymerase chain reaction analysis of corneal and limbal epithelial
genes (B). Data are presented as mean6 SEM, n5 3. Scale bar5 50 mm. *, statistically different compared with G1. *, p< .05; **, p< .01.
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replicated early developmental mechanisms by blocking the
TGFb and Wnt-signaling pathways with small-molecule inhibi-
tors and activating fibroblast growth factor (FGF) signaling
[27] to generate corneal epithelial-like progenitor cells capable
of terminal differentiation toward mature corneal epithelial-
like cells within 44 days. TGF-b pathway has been shown to
play multiple roles in maintenance of pluripotency and early
cell fate decisions. Work done by other groups [47] and this
group [48] has shown that low activity of this pathway (either
through application of inhibitors or low endogenous activity)
results in neuroectodermal default pathway which skews plu-
ripotent stem cells away from non-neural ectoderm and cor-
neal epithelial differentiation. For this reason, we designed
our differentiation protocol to include growth factors and
morphogens (BMP4, RA, and EGF) that have been shown to
promote non-neural ectodermal commitment [31, 32, 49, 50]
and proliferation of corneal epithelial progenitors. In the sec-
ond window of differentiation, we attempted to replicate the
LSCs niche by coating the cell surfaces with collagen-IV shown
to be the key component of limbal stroma and [51, 52] and
Figure 5. DNp63 protein expression and colony forming efficiency at day 20 of differentiation. Percentage of DNp63 positive cells for
H9, SB-Ad2, and SB-Ad3 cells on day 20 for G1, G2, G3, and G5 (A). Colony forming efficiency for the three cell lines on day 20 for G1,
G2, G3 G5, and human limbal epithelium (B). Data are presented as mean6 SEM, n5 3. *, statistically different compared with G1 of
the same cell line. *, p< .05; **, p< .01; ***, p< .001; ****, p< .0001. #, statistically different compared with the other group; ##,
p< .01. Abbreviation: CFE, colony forming efficiency.
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feeding the cells with a defined media (CnT-Prime) which is
used to maintain the ex vivo expansion of human corneal epi-
thelial progenitors [53]. This two-step differentiation protocol
resulted in successful generation of hESC-derived corneal epi-
thelial progenitors with colony forming ability similar to limbal
epithelial progenitors within a window of 20 days.
Since the main aim of this study was to design robust differ-
entiation protocols for differentiation of hiPSC to corneal
epithelial-like cells for autologous cell replacement therapies, we
tested the two-step differentiation protocol in two hiPSC lines
generated and well characterized by our laboratory [54]. One of
the hiPSC lines was able to generate corneal epithelial progeni-
tors with colony forming ability in response to BMP4, RA, or com-
bined addition of BMP4, RA, and EGF, although at lower levels
than hESC. In contrast, the second tested hiPSC line was not able
to respond to the step differentiation protocol resulting in low
levels of corneal epithelial progenitor generation. Differences in
transcriptional and epigenetic profiles between hiPSC lines which
are linked to their differentiation capacity are commonly encoun-
tered, especially during directed differentiations, where specific
molecules were used to alter the pathways of interest. A study
published by our group indicated that hiPSC lines that possess
higher level of mitochondrial protein CHCHD2, have a less active
TGFb signaling activity, making them more prone to neural differ-
entiation [48]. A recent report by Nishizawa et al. also indicated
that haematopoietic commitment of hiPSC lines depends on the
expression of insulin-like growth factor 2 (IGF2) [55]. Earlier, Fuji-
wara et al. found variations in the basal cardiomyocyte differenti-
ation efficiency of hiPSC lines which was overcomed by using
Cyclosporin-A [56]. Together, these studies suggest that differenti-
ation protocols may need to be adjusted to take into account the
endogenous expression of key transcription and growth factors
as well as signaling pathways that govern early differentiation
steps.
Figure 6. SB431542 exposure during early differentiation enhanced the hiPSC differentiation to corneal epithelial progenitors. Sche-
matic outline for optimization experiment using SB431542 (A). Quantitative real-time polymerase chain reaction analysis of the putative
limbal stem cells (DNp63) gene for SB-Ad3 cells from G5 subgroups on day 20 of optimization experiment following different durations
of SB431542 exposure (B). Colony forming efficiency assays for the SB431542 exposed and unexposed G5 subgroups on day 20 (C). Data
presented as mean6 SEM, n5 3. *, statistically different compared with untreated group. **, p< .01; ***, p< .001; ****, p< .0001.
ns, no significant difference. Abbreviations: CFE, colony forming efficiency; ICC, immunocytochemistry; FBS, fetal bovine serum; qPCR,
quantitative polymerase chain reaction.
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Endogenous BMP signaling activity is different in various
hiPSC lines and crosstalk between BMP and TGFb signaling
has also been reported [57], affecting the propensity of each
cell line during differentiation process. Given the importance
of BMP4 signaling in inhibiting neural differentiation and pro-
moting epidermal commitment of embryonic stem cells [32,
58, 59], we investigated the level of endogenous BMP path-
way activity using reporter based assays and qRT-PCR. These
experiments indicated that the nonresponsive hiPSC line had
lower level of BMP signaling activity which was caused by a
lower expression of effectors and receptors, resulting in low
expression of BMP target genes. To restore the differentiation
potential we used a specific TGFb inhibitor, SB431542, which
changed the balance of co-SMADS into the favor of BMP sig-
naling resulting in successful differentiation of the non-
responsive hiPSC to corneal epithelial progenitors. Our find-
ings closely corroborate those published by Shalom-Feuerstein
et al. [42] who reported improved differentiation of hiPSC to
epidermal lineages upon addition of SB431542 to BMP4 and
ascorbic acid supplemented media. A different small molecule
TGFb inhibitor was used by Mikhailova et al. to guide differ-
entiation of hiPSC to corneal epithelial progenitor cells in
combination with a Wnt inhibitor, IWP-2, and FGF [27].
Although SB505124 is reported to be more selective than
SB431542 for inhibiting TGFb signaling [60], the supplementa-
tion of the former inhibitor and IWP-2 alone or in combina-
tion with BMP4 in our setting failed to activate expression of
key epithelial and LSCs markers, suggesting crosstalk between
signaling pathways is essential for guiding differentiation of
pluripotent stem cells to corneal epithelial lineages.
Similarly to other published studies in the field, our
method generated a high percentage of DNp63-positive cells
in the first window of differentiation which went on to fur-
ther mature to CK3 and CK12 positive corneal epithelial cells.
In addition, this study indicated that the hESC and hiPSC
derived epithelial progenitors have a high colony forming effi-
ciency which was comparable with limbal epithelial progenitor
cells obtained from adult human cornea.
CONCLUSION
In summary, this article describes a new two-step differentia-
tion method with which minor modifications can be applied
to generate corneal epithelial progenitor cells in a short time
from a large range of hESC and hiPSC. However, further work
in animal models of total LSCD needs to be carried out to
test the engraftment and functionality of hESC- and hiPSC-
derived corneal epithelial progenitor cells.
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